Digital interventions for self-management of prediabetes: A scoping review DOI Creative Commons
Melanie Stowell, Rosie Dobson, Katie Garner

и другие.

PLoS ONE, Год журнала: 2024, Номер 19(5), С. e0303074 - e0303074

Опубликована: Май 10, 2024

Background Rates of prediabetes, which can lead to type 2 diabetes, are increasing worldwide. Interventions for prediabetes mainly focus on lifestyle changes diet and exercise. While these interventions effective, they often delivered face-to-face, may pose a barrier those with limited access healthcare. Given the evidence digital addressing other noncommunicable diseases, also be effective self-management. The aim this scoping review was assess breadth around Methods We developed targeted search strategy relevant studies were identified through searches conducted in four bibliographic databases (Medline, Embase, PsycInfo, Scopus). Published eligible if included intervention support adults aged 18+ Titles abstracts first screened relevance by one researcher. Full texts selected records assessed against criteria independently two researchers inclusion final analysis. Results Twenty-nine included, nine randomised controlled trials. Most efficacy reported significant at least primary and/or secondary outcome, including participants’ glycaemic control, weight loss physical activity levels. About one-third mixed outcomes or early that not sustained long-term follow-up. varied length, modalities, complexity. Delivery formats text messages, mobile apps, virtually accessible dietitians/health coaches, online peer groups, web-based platforms. Approximately half participant engagement/acceptability outcomes. Conclusion Whilst here suggests self-management acceptable have potential reduce one’s risk progression more research is needed understand interventions, components specifically, greatest reach diverse populations, most promoting user engagement, longer term.

Язык: Английский

Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement DOI Creative Commons
L. Rosta,

Adrienn Menyhart,

Wael Al Mahmeed

и другие.

Frontiers in Endocrinology, Год журнала: 2023, Номер 14

Опубликована: Май 17, 2023

The past two decades have witnessed telemedicine becoming a crucial part of health care as method to facilitate doctor-patient interaction. Due technological developments and the incremental acquisition experience in its use, telemedicine’s advantages cost-effectiveness has led it being recognised specifically relevant diabetology. However, pandemic created new challenges for healthcare systems rate development digital services started grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk both mortality debilitating sequelae. In addition, observed this higher could be attenuated primarily by maintaining optimal control patient’s glucose metabolism. As opportunities actual physical visits became restricted, provided most convenient opportunity communicate maintain delivery care. wide range experiences provision during several excellent strategies regarding applicability across whole spectrum continuation these is likely benefit clinical practice even after crisis over.

Язык: Английский

Процитировано

16

The prevalence of long COVID in people with diabetes mellitus–evidence from a UK cohort DOI Creative Commons
Adrian Heald, Richard Williams, David Jenkins

и другие.

EClinicalMedicine, Год журнала: 2024, Номер 71, С. 102607 - 102607

Опубликована: Апрель 17, 2024

BackgroundIt was apparent from the early phase of SARS-CoV-2 virus (COVID-19) pandemic that a multi-system syndrome can develop in weeks following COVID-19 infection, now referred to as Long COVID. Given people living with diabetes are at increased risk hospital admission/poor outcomes infection we hypothesised they may also be more susceptible developing We describe here prevalence COVID when compared matched controls Northwest UK population.MethodsThis retrospective cohort study who had recorded diagnosis type 1 (T1D) or 2 (T2D) were alive on 1st January 2020 and proven infection. used electronic health record data Greater Manchester Care Record collected 16th September 2023, determined T1D T2D vs individuals without (non-DM).FindingsThere 3087 14,077 non-diabetes 29,700 119,951 controls. For T1D, there lower proportion and/or referral service 0.33% 0.48% for The In 0.53% 1:3 0.54%. T2D, differences by sex comparison between males their controls, 0.46%.vs 0.54% (0.008). When considering LC females higher 0.61% (0.007). not different. patients older younger age reduced (OR 0.994 [95% CI) [0.989, 0.999]). minor increase 1.179, 95% CI [1.002, 1.387]). Presence body mass index (BMI) associated an 1.013, [1.001, 1.026]). estimated general population based practice coding (not self-reported) this 0.5% prior acute diagnosis.InterpretationRecorded prevalent men than non-T2D opposite seen women, rates being similar women. Younger age, female BMI all greater likelihood taken individual variables. There remains imperative continuing awareness differential symptomatic presentation context previous infection.FundingThe time co-author RW supported NIHR Applied Research Collaboration (NIHR200174) Biomedical Centre (NIHR203308).

Язык: Английский

Процитировано

5

Cross-Talk of NADPH Oxidases and Inflammation in Obesity DOI Creative Commons
Henning Morawietz, Heike Brendel, Patrick Diaba‐Nuhoho

и другие.

Antioxidants, Год журнала: 2023, Номер 12(8), С. 1589 - 1589

Опубликована: Авг. 9, 2023

Obesity is a major risk factor for cardiovascular and metabolic diseases. Multiple experimental clinical studies have shown increased oxidative stress inflammation linked to obesity. NADPH oxidases are sources of reactive oxygen species in the system metabolically active cells organs. An impaired balance due formation reduced antioxidative capacity contributes pathophysiology diseases as pathomechanism cardiometabolic Non-alcoholic fatty liver disease particularly characterized by inflammation. In recent years, COVID-19 infections also infected tissues. Increasing evidence supports idea an severe complications after COVID-19. this review, we discuss role models obesity, diseases, potential therapeutic strategies.

Язык: Английский

Процитировано

11

Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19 DOI Creative Commons
Łukasz Lewandowski, Agnieszka Bronowicka-Szydełko, Maciej Rabczyński

и другие.

Biomedicines, Год журнала: 2024, Номер 12(3), С. 605 - 605

Опубликована: Март 7, 2024

Due to the molecular mechanisms of action antidiabetic drugs, they are considered be effective in treatment both COVID-19 and post-COVID-19 syndromes. The aim this study was determine effect administering insulin metformin on mortality patients with type 2 diabetes (T2DM) symptomatic use logistic regression models. association between death weak could not included multivariate model. However, interaction drugs other factors, including remdesivir low-molecular-weight heparin (metformin), age hsCRP (insulin), modulated odds death. These interactions hint at multifaceted (anti-/pro-) associations death, depending patient’s characteristics. In model, RDW-SD, adjusted treatment, age, sex K+, associated among T2DM. With a 15% increase risk increased by 87.7%. This preliminary provides foundations for developing further, more personalized models assess T2DM patients, as well identifying an due COVID-19.

Язык: Английский

Процитировано

4

Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates DOI Creative Commons
Aysha Alkhemeiri, Ziad El‐Khatib, Ali Al-Ameri

и другие.

Journal of Epidemiology and Global Health, Год журнала: 2025, Номер 15(1)

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

0

Impact of COVID-19 on preexisting comorbidities DOI
Rasha Ashmawy,

Esraa Abdellatif Hamouda,

Sally Zeina

и другие.

Progress in molecular biology and translational science, Год журнала: 2025, Номер unknown, С. 215 - 258

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Association of Mediterranean Diet with Cardiovascular Risk Factors and with Metabolic Syndrome in Subjects with Long COVID: BioICOPER Study DOI Open Access
Nuria Suárez-Moreno, Leticia Gómez‐Sánchez, Alicia Navarro-Cáceres

и другие.

Nutrients, Год журнала: 2025, Номер 17(4), С. 656 - 656

Опубликована: Фев. 12, 2025

Long COVID has been associated with increased cardiovascular risk and chronic low-grade inflammation, raising concerns about its long-term metabolic consequences. Given that the Mediterranean diet (MD) shown beneficial effects on factors inflammation in various populations, it is important to explore potential impact individuals COVID. Therefore, aim determine association of MD (CVRF) syndrome (MetS) Caucasian subjects diagnosed Cross-sectional study, 305 were included following WHO criteria. Adherence was evaluated MEDAS (Mediterranean Diet Screener) 14 items used Prevention study (PREDIMED study). The criteria considered diagnose MetS blood pressure, glycemia, triglycerides, HDL cholesterol, waist circumference. Other CVRFs tobacco consumption, total LDL body mass index, baseline uric acid levels. between CVRF number components analyzed using multiple regression models multinomial regression. mean age 52.75 ± 11.94 years (men 55.74 12.22 women 51.33 11.57; p = 0.002), (68% women). questionnaire 7.76 2.37. presented 23.6% (39.8% men 15.9% < 0.001). In analysis, after adjusting for average time from acute COVID-19 infection date inclusion this score showed a negative (β -0.295; 95% CI: -0.496 -0.093), BMI -0.049; -0.096 -0.002), -0.210; -0.410 -0.010), circumference (WC) -0.021; -0.037 -0.003) positive cholesterol -0.018; 0.001 -0.037). findings suggest higher scores are lower levels acid, fewer components, smaller circumference,

Язык: Английский

Процитировано

0

The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19 DOI Creative Commons

L. R. Craciun,

Flavia Ignuta,

Uma Shailendri Rayudu

и другие.

Biomedicines, Год журнала: 2025, Номер 13(4), С. 886 - 886

Опубликована: Апрель 6, 2025

Background and Objectives: Patients with type 2 diabetes mellitus (T2DM) are at a heightened risk of adverse outcomes from Coronavirus Disease 2019 (COVID-19). However, the influence glycemic control on systemic inflammation clinical severity remains incompletely understood. This study aimed to compare inflammatory markers, composite scores, between T2DM patients COVID-19 who had well-controlled (hemoglobin A1c < 7%) versus those poorly controlled ≥ 7%). Methods: We retrospectively reviewed 181 adult severe admitted tertiary hospital January 2022 December 2023. were divided into two groups: (n = 117) 64) T2DM. Baseline demographics, comorbidities, laboratory parameters (C-reactive protein, interleukin-6, ferritin, neutrophil lymphocyte counts, platelets, calculated indices such as neutrophil-to-lymphocyte ratio [NLR] immune-inflammation index [SII]) collected. Composite scores (APACHE II, CURB-65, NEWS) (ICU admission, mechanical ventilation, mortality, length stay) compared. Statistical tests used included Student’s t-test or Mann–Whitney U for continuous variables chi-square categorical variables, p 0.05 deemed significant. Results: The groups did not differ significantly in age duration (p 0.40 0.75, respectively). exhibited higher markers (mean CRP 93.4 mg/L vs. 78.6 mg/L, 0.002; IL-6 64.2 pg/mL 52.8 pg/mL, 0.004) elevated II 16.8 14.1, 0.001). Poor was associated ICU admissions (39.1% 22.2%, 0.02) mortality (14.1% 6.0%, 0.05). Conclusions: In hospitalized COVID-19, poor correlates responses, worse increased rates unfavorable outcomes. These findings underscore necessity stringent glucose management mitigate improve prognoses this vulnerable patient population.

Язык: Английский

Процитировано

0

Physical activity level one year following admission to the intensive care unit for COVID-19 DOI Creative Commons
Netha Hussain, Carina M. Samuelsson, Mats Börjesson

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Апрель 22, 2025

Язык: Английский

Процитировано

0

Age-associated changes in the heart: implications for COVID-19 therapies DOI Creative Commons

Colby Wood,

Zach Saltera,

Irvin Jither Garcia

и другие.

Aging, Год журнала: 2025, Номер unknown

Опубликована: Май 13, 2025

Cardiac aging involves progressive structural, functional, cellular, and molecular changes that impair heart function. This review explores key mechanisms, including oxidative stress, mitochondrial dysfunction, impaired autophagy, chronic low-grade inflammation. Excess reactive oxygen species (ROS) damage muscle cells, contributing to fibrosis cellular aging. Mitochondrial dysfunction reduces energy production increases accelerating cardiac decline. Impaired autophagy limits the removal of damaged proteins organelles, while inflammation activates signaling molecules drive tissue remodeling. Gender differences reveal estrogen's protective role in premenopausal women, with men showing greater susceptibility injury. After menopause, women lose this hormonal protection, increasing their risk cardiovascular conditions. Ethnic disparities, particularly among underserved minority populations, emphasize how social factors such as access care, environment, stress contribute worsening outcomes. The coronavirus disease pandemic has introduced further challenges by incidence through inflammation, blood clots, long-term failure, especially older adults existing metabolic conditions like diabetes high pressure. virus's interaction receptors on vessel along a weakened immune response adults, intensifies Emerging therapies include delivery therapeutic extracellular vesicles, cell modulation, treatments targeting mitochondria. In addition, lifestyle strategies regular physical activity, nutritional improvements, reduction remain vital maintaining health. Understanding these biological intersect is critical developing targeted promote healthy heart.

Язык: Английский

Процитировано

0